Rapport Therapeutics, Inc. Common StockShare Price
|
|
Share Price & Volume
| Previous Close | $34.17 | |
| Open | +0.26% | $34.26 |
| Day Low | -0.50% | $34.00 |
| Day High | +3.95% | $35.52 |
| 52-Week Low | -77.38% | $7.73 |
| 52-Week High | +23.70% | $42.27 |
| Day Volume | 138,922 | |
| Average Volume | 321,118 | |
| EPS (TTM) | -$2.86 | |
| P/E (TTM) | -12.12x | |
| FWD P/E (NTM) | - | |
| Next Earnings Date | May 7, 2026 |
| Market Cap | 1,264,642,464 | |
| Shares Outstanding (Millions) | 36,497,618 | |
| Dividend | - | |
| Beta | - | |
| ROE | -0.28% | |
| ROA | -0.19% |
Analyst Ratings and Price Targets
Current:
$34.65
Average:
$47.33
(+36.60%)
Low:
$43.00
(+24.10%)
High:
$53.00
(+52.96%)
You need to login to see this data
| BTIG | Maintains | Buy | $53.00 | +52.96% | Mar 10, 2026 |
| Wells Fargo | Maintains | Overweight | $46.00 | +32.76% | Mar 10, 2026 |
| Wells Fargo | Initiates Coverage On | Overweight | $43.00 | +24.10% | Feb 2, 2026 |
Headquarters
Boston, DE, USA
Sector
Industry
# of Employees
69